Journal article
Metronidazole-induced Encephalopathy
IDCases, Vol.18, pp.e00639-e00639
01/01/2019
DOI: 10.1016/j.idcr.2019.e00639
PMCID: PMC6804936
PMID: 31692663
Abstract
Metronidazole is commonly used in the treatment of anaerobic infections. While neuropathy is known to be associated with metronidazole, encephalopathy has been rarely reported. We herein present a case of metronidazole-induced encephalopathy presenting as frequent falls and slurred speech. Magnetic resonance imaging of the brain demonstrated T2/FLAIR hyperintensity in the dentate nuclei bilaterally. Soon after the discontinuation of metronidazole, dysarthria and dysmetria resolved. Metronidazole-induced encephalopathy should be considered in patients presenting with new neurologic symptoms after the initiation of metronidazole. (C) 2019 The Authors. Published by Elsevier Ltd.
Details
- Title: Subtitle
- Metronidazole-induced Encephalopathy
- Creators
- Htay Phyu - University of IowaMichael B. Edmond - University of Iowa Hospitals and ClinicsTakaaki Kobayashi - University of Iowa Hospitals and Clinics
- Resource Type
- Journal article
- Publication Details
- IDCases, Vol.18, pp.e00639-e00639
- DOI
- 10.1016/j.idcr.2019.e00639
- PMID
- 31692663
- PMCID
- PMC6804936
- NLM abbreviation
- IDCases
- ISSN
- 2214-2509
- eISSN
- 2214-2509
- Publisher
- Elsevier
- Number of pages
- 2
- Language
- English
- Date published
- 01/01/2019
- Academic Unit
- Infectious Diseases; Internal Medicine
- Record Identifier
- 9984359670302771
Metrics
10 Record Views